Edgewise taps new chief medical officer
BOULDER — Edgewise Therapeutics Inc. (Nasdaq: EWTX) has hired Dr. Joanne Donovan as its chief medical officer as the company […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
Edgewise Therapeutics reports continued successful drug trials, $17.4M loss in third quarter
BOULDER — Edgewise Therapeutics Inc. (Nasdaq: EWTX) reported continued successful drug trials in the third quarter of 2022 as the…
Biotechnology boom
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
Edgewise Therapeutics receives FDA approval for muscular dystrophy drug trials, launches stock offering
BOULDER — Edgewise Therapeutics Inc. (Nasdaq: EWTX) has received authorization from the U.S. Food and Drug Administration to conduct Phase…
Edgewise grows R&D expenses, losses in fourth quarter
BOULDER — Clinical-stage, pre-revenue pharmaceutical company Edgewise Therapeutics Inc. (Nasdaq: EWTX) posted higher year-over-year losses in the fourth quarter of…